NOT JUST ACIDITY: UNDERSTANDING STOMACH ULCERS
Article Sidebar
Main Article Content
Аннотация:
Stomach ulcers, clinically referred to as gastric ulcers, represent a multifactorial gastrointestinal disorder rather than a condition caused solely by excessive gastric acid. Contemporary medical research has demonstrated that mucosal defense impairment, Helicobacter pylori infection, nonsteroidal anti-inflammatory drug (NSAID) use, and microcirculatory dysfunction play decisive roles in ulcer pathogenesis. This thesis aims to analyze the etiology, pathophysiological mechanisms, diagnostic approaches, and clinical outcomes of stomach ulcers using evidence-based medical literature. Emphasis is placed on understanding gastric ulcers as a result of disrupted equilibrium between aggressive factors and protective mechanisms of the gastric mucosa. The study highlights the necessity of an integrated diagnostic and therapeutic strategy beyond acid suppression alone.
Article Details
Как цитировать:
Библиографические ссылки:
Kumar, V., Abbas, A.K., Aster, J.C. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Elsevier, 2015, pp. 775–778.
Feldman, M., Friedman, L.S., Brandt, L.J. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 10th ed. Elsevier, 2016, pp. 834–842.
Marshall, B.J., Warren, J.R. “Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.” The Lancet, 1984, Vol. 1, pp. 1311–1315.
Laine, L. “Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient.” Gastroenterology, 2001, Vol. 120, pp. 594–606.
Katz, P.O., Gerson, L.B., Vela, M.F. Clinical Gastroenterology. McGraw-Hill, 2013, pp. 412–418.
Talley, N.J., Ford, A.C. “Functional dyspepsia.” New England Journal of Medicine, 2015, Vol. 373, pp. 1853–1863.
Wallace, J.L. “Prostaglandins, NSAIDs, and gastric mucosal protection.” Gastroenterology Clinics, 2001, Vol. 30, pp. 863–875.
Malfertheiner, P. et al. “Management of Helicobacter pylori infection.” Gut, 2017, Vol. 66, pp. 6–30.
Lanas, A., Chan, F.K.L. “Peptic ulcer disease.” The Lancet, 2017, Vol. 390, pp. 613–624.
Soll, A.H. “Pathogenesis of peptic ulcer and implications for therapy.” New England Journal of Medicine, 1990, Vol. 322, pp. 909–916.
Kusters, J.G., van Vliet, A.H.M., Kuipers, E.J. “Pathogenesis of Helicobacter pylori infection.” Clinical Microbiology Reviews, 2006, Vol. 19, pp. 449–490.
Cryer, B., Feldman, M. “Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used NSAIDs.” American Journal of Medicine, 1998, Vol. 104, pp. 413–421.